THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 172 participants.

Also called NCT01385202

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 172 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01385202
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01385202. Allocation not applicable; no masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2013-02 (actual). Results posted on 2015-01-26.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation
Condition
Heart Diseases
Condition
Arrhythmia
Intervention (Device)
THERMOCOOL® SMARTTOUCH™ Catheter
Lead sponsor
Biosense Webster, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01385202
Content hash
4330e7f49116a3091608944a9b36d13edf8ea6ba77559c99db220e1140760c56